All terms in EFO
| Label | Id | Description |
|---|---|---|
| 1-linoleoylglycerol 1-monolinolein measurement | EFO_0021108 | [Quantification of the amount of 1-linoleoylglycerol 1-monolinolein in a sample.] |
| HWESASXX measurement | EFO_0021147 | [Quantification of the amount of HWESASXX in a sample.] |
| bradykinin, des-arg 9 measurement | EFO_0021146 | [Quantification of the amount of bradykinin, des-arg 9 in a sample.] |
| 4-vinylphenol sulfate measurement | EFO_0021149 | [Quantification of the amount of 4-vinylphenol sulfate in a sample.] |
| 4-ethylphenylsulfate measurement | EFO_0021148 | [Quantification of the amount of 4-ethylphenylsulfate in a sample.] |
| gamma-glutamylthreonine measurement | EFO_0021143 | [Quantification of the amount of gamma-glutamylthreonine in a sample.] |
| hemoglobin D disease | MONDO_0019537 | [Hemoglobin D disease(HbD) is a hemoglobinopathy characterized by production of abnormal variant hemoglobin known as hemoglobin D, with no or mild clinical manifestations (splenomegaly, very mild anemia).] |
| acute megakaryoblastic leukemia in down syndrome | MONDO_0020526 | |
| gamma-glutamylphenylalanine measurement | EFO_0021142 | [Quantification of the amount of gamma-glutamylphenylalanine in a sample.] |
| transient neonatal diabetes mellitus | MONDO_0020525 | [Transient neonatal diabetes mellitus (TNDM) is a genetically heterogeneous form of neonatal diabetes (NDM) characterized by hyperglycemia presenting in the neonatal period that remits during infancy but recurs in later life in most patients.] |
| gamma-glutamylvaline measurement | EFO_0021145 | [Quantification of the amount of gamma-glutamylvaline in a sample.] |
| primary parathyroid hyperplasia | MONDO_0020524 | |
| gamma-glutamyltyrosine measurement | EFO_0021144 | [Quantification of the amount of gamma-glutamyltyrosine in a sample.] |
| familial parathyroid adenoma | MONDO_0020523 | [An instance of parathyroid gland adenoma that is caused by an inherited modification of the individual's genome.] |
| parathyroid adenoma | EFO_1001087 | [A benign tumor arising from the parenchymal cells of the parathyroid glands. In the vast majority of cases, the tumor involves a single parathyroid gland. It is associated with the symptoms of primary hyperparathyroidism, resulting from the excessive production of parathyroid hormone. It is usually surrounded by a well-defined capsule. Capsular invasion, vascular invasion, and perineural invasion are absent.] |
| interleukin 15 receptor subunit alpha measurement | EFO_0008172 | [quantification of the amount of interleukin 15 receptor subunit alpha in a sample] |
| interleukin 16 measurement | EFO_0008173 | [quantification of the amount of interleukin 16 in a sample] |
| gamma-glutamylmethionine measurement | EFO_0021141 | [Quantification of the amount of gamma-glutamylmethionine in a sample.] |
| interleukin 17 measurement | EFO_0008174 | [quantification of the amount of interleukin 17 in a sample] |
| interleukin 17 receptor A measurement | EFO_0008175 | [quantification of the amount of interleukin 17 receptor A in a sample] |